Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by JAMES P ALLISON and NAVEEN SHARMA.
JAMES P ALLISON
Connection Strength
1.968
NAVEEN SHARMA
  1. ICOS costimulation in combination with CTLA-4 blockade remodels tumor-associated macrophages toward an antitumor phenotype. J Exp Med. 2024 Apr 01; 221(4).
    View in: PubMed
    Score: 0.954
  2. LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy. J Exp Med. 2021 07 05; 218(7).
    View in: PubMed
    Score: 0.782
  3. TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion. Proc Natl Acad Sci U S A. 2019 05 21; 116(21):10453-10462.
    View in: PubMed
    Score: 0.170
  4. Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy. Nature. 2024 Aug; 632(8023):182-191.
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.